Palonosetron

FDA Approved: * November 21, 2017
Pharm Company: * FRESENIUS KABI USA
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Palonosetron Overview

Palonosetron (INN, trade name Aloxi) is a 5-HT3 antagonist used in the prevention and treatment of chemotherapy-induced nausea and vomiting (CINV). It is used for the control of delayed CINV—nausea and vomiting and there are tentative data to suggest that it may be more effective than granisetron.[1] Palonosetron is administered intravenously, as a single dose, 30 minutes before chemotherapy,[2] or as a single oral capsule one hour before chemotherapy.&am...

Read more Palonosetron Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Palonosetron

Recent Palonosetron Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Palonosetron
  • Capsule: 0.5mg
  • Injection: 0.075mg/1.5ml (0.05mg/ml), 0.25mg/5ml, 0.25mg/5ml (0.05mg/ml)
  • Solution: 0.25mg/5ml, 0.25mg/5ml (0.05mg/ml)
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Palonosetron: (21 results)

Showing the first 20, Sorted by National Drug Code
  • 0143-9513 Palonosetron Hydrochloride .25 mg/2ml Intravenous Injection by West-ward Pharmaceuticals Corp
  • 0409-2504 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Hospira, Inc.
  • 0703-4094 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Teva Parenteral Medicines, Inc.
  • 0781-3312 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Sandoz Inc
  • 0781-3415 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Sandoz Inc
  • 16714-834 Palonosetron .05 mg/ml Intravenous Injection, Solution by Northstar Rx LLC
  • 16729-365 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection by Accord Healthcare, Inc.
  • 25021-783 Palonosetron Hydrochloride .05 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 25021-788 Palonosetron Hydrochloride .05 mg/ml Intravenous Injection, Solution by Sagent Pharmaceuticals
  • 55111-694 Palonosetron .05 mg/ml Intravenous Injection, Solution by Dr.reddy's Laboratories Limited
  • 55150-186 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Auromedics Pharma LLC
  • 60505-6193 Palonosetron .25 mg/5ml Intravenous Injection by Apotex Corp.
  • 63323-673 Palonosetron .25 mg/5ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
  • 63323-942 Palonosetron .25 mg/5ml Intravenous Injection, Solution by Fresenius Kabi USA, LLC
  • 67184-0514 Palonosetron .25 mg/5ml Intravenous Injection by Qilu Pharmaceutical Co., Ltd.
  • 67184-0515 Palonosetron .075 mg/1.5ml Intravenous Injection by Qilu Pharmaceutical Co., Ltd.
  • 67457-317 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Mylan Institutional LLC
  • 68001-355 Palonosetron .05 mg/ml Intravenous Injection, Solution by Bluepoint Laboratories
  • 69097-439 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection, Solution by Cipla USA Inc.
  • 69097-927 Palonosetron Hydrochloride .25 mg/5ml Intravenous Injection by Cipla USA Inc.
  • 1 more results ...

Other drugs which contain Palonosetron or a similar ingredient: (3 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 15 November 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA